Biopsy procedure volumes will continue to grow at a modest rate through 2028, driven by favorable demographic trends, the development of more accurate testing methods, improved imaging technologies, as well as updated recommendations to screening guidelines.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biopsy devices in the US across a 10-year period.


Biopsy volumes in the US will be impacted by demographic factors, advances in imaging technology, and various initiatives in screening programs. 

How are the various imaging technologies being adopted in the US for biopsy?

How will imaging technologies and screening programs impact the different biopsy device market segments?

How has screening participation impacted biopsy procedure volumes in US?

Minimally invasive, alternative technologies to tissue biopsy are being adopted by physicians in the US.

To what extent are physicians adopting these minimally invasive technologies?

How will the adoption of alternative technologies impact the biopsy device market?

Companies are adopting various strategies to strengthen their positions in the biopsy device market.

What are the major strategies that companies are implementing?

How will the entry of low-cost competitors influence pricing and growth of leading companies?

Table of contents

  • United States
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Physician Training and Marketing
        • Product Improvements and Innovations
        • Mergers, Acquisitions, and Partnerships
        • Competition from Alternatives
        • Pricing Strategies and Purchasing Options
      • Market Developments
    • Percutaneous Soft Tissue Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Vacuum-Assisted Biopsy Devices
        • Core Needle Biopsy Devices
        • Fine Needle Aspiration Needles
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Product Improvements and Innovations
        • Mergers, Acquisitions, and Partnerships
    • Bone Marrow Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Gastrointestinal Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Biopsy Forceps
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Bronchial Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Biopsy Forceps
        • TBNA Needles
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Gynecological Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Percutaneous Drainage Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Sanketh Kamath, MBA

Sanketh Kamath is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, specializing in urology, gynecology, diagnostic imaging systems, drug delivery devices, and medical device outsourcing. He has also worked on procedure claims code alignment for DRG's US Procedure Finder product. Sanketh holds an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, India. Follow Sanketh on twitter: @ksankethb_DRG


Related Reports

Biopsy Devices | Medtech 360 | Market Insights | Europe

The European biopsy device market will continue to grow modestly through 2028, driven largely by growth in the percutaneous soft tissue biopsy...

View Details

Breast Biopsy Devices | Medtech 360 | Market Insights | Global

The moderate growth of the global breast biopsy device market will be driven primarily by the increasing awareness of breast cancer screening in developing markets like China a...

View Details

Biopsy Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for biopsy devices will be driven primarily by wider implementation of national cancer screening programs, an increase in reimbursement coverage for biopsy procedures, increa...

View Details